Su Lebin, Dong Jianyu, Shen Yang, Xie Shimin, Wu Shaofeng, Pan Neng, Liu Feng, Shang Qian, Cai Fangfang, Ren Tian-Bing, Yuan Lin, Yin Shuang-Feng, Han Li-Biao, Zhou Yongbo
State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, China.
School of Physics and Chemistry, Hunan First Normal University, Changsha, China.
Nat Commun. 2025 Jan 2;16(1):169. doi: 10.1038/s41467-024-54190-5.
(Hetero)polyaryl amines are extensively prevalent in pharmaceuticals, fine chemicals, and materials but the intricate and varied nature of their structures severely restricts their synthesis. Here, we present a selective multicomponent cycloaromatization of structurally and functionally diverse amine substrates for the general and modular synthesis of (hetero)polyaryl amines through copper(I)-catalysis. This strategy directly constructs a remarkable range of amino group-functionalized (hetero)polyaryl frameworks (194 examples), including naphthalene, binaphthalene, phenanthren, benzothiophene, dibenzothiophene, benzofuran, dibenzofuran, quinoline, isoquinoline, quinazoline, and others, which are challenging or impossible to obtain using alternative methods. Copper(III)-acetylide species are involved in driving the exclusive 7-endo-dig cyclization, suppressing many side-reactions that are susceptible to occur. Due to the easy introduction of various functional units into heteropolyarylamines, multiple functionalized fluorescent dyes can be arbitrarily synthesized, which can serve as effective fluorescent probes for monitoring the pathological processes (e.g. chemotherapy-induced cell apoptosis) and studying the related disease mechanisms.
(杂)多芳基胺广泛存在于药物、精细化学品和材料中,但其结构复杂多样,严重限制了它们的合成。在此,我们展示了一种通过铜(I)催化对结构和功能多样的胺底物进行选择性多组分环芳构化反应,用于(杂)多芳基胺的通用模块化合成。该策略直接构建了一系列引人注目的氨基官能化(杂)多芳基骨架(194个实例),包括萘、联萘、菲、苯并噻吩、二苯并噻吩、苯并呋喃、二苯并呋喃、喹啉、异喹啉、喹唑啉等,这些是使用其他方法具有挑战性或无法获得的。铜(III)-乙炔化物物种参与驱动专一的7-内型-环化反应,抑制了许多易发生的副反应。由于能够轻松地将各种功能单元引入杂多芳基胺中,可以任意合成多种功能化荧光染料,它们可作为有效的荧光探针来监测病理过程(如化疗诱导的细胞凋亡)并研究相关疾病机制。